Author Question: A client has had the following problems identified: ineffective coping related to mastectomy for ... (Read 66 times)

DyllonKazuo

  • Hero Member
  • *****
  • Posts: 565
A client has had the following problems identified: ineffective coping related to mastectomy for
  breast cancer, deficient knowledge of cancer treatment options, dysfunctional grieving related to
  perception of loss, and disturbed body image related
 
  to mastectomy. A psychiatric mental health
  liaison nurse has been called. The problem that the liaison nurse should suggest an oncology nurse
  address is
  a. ineffective coping.
  b. deficient knowledge.
  c. dysfunctional grieving.
  d. disturbed body image.

Question 2

A client lists the following problems: I have no sense of self-worth. I constantly think negative
  thoughts about myself. I feel anxious and shaky all the time. Sometimes my mood is so low that I
  think I want to go to sleep and never wake up.
 
  . The nursing interventions that should be accorded
  the highest priority relate to outcomes associated with
  a. self-esteem.
  b. anxiety self-control.
  c. depression self-control.
  d. suicide self-restraint.



gstein359

  • Sr. Member
  • ****
  • Posts: 293
Answer to Question 1

ANS: B
The psychiatric mental health liaison nurse will intervene in the phenomena of emotional stress
components of illness, self-concept changes, and grief. The knowledge deficit will be important to
address but is the domain of an oncology nurse.

Answer to Question 2

ANS: D
The nurse would place a priority on monitoring and reinforcing suicide self-restraint because it
relates directly and immediately to client safety. Client safety is always a priority concern. The nurse
would also be expected to monitor and reinforce all client attempts to control anxiety, control
depression, and develop self-esteem while giving priority attention to suicide self-restraint.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

More than nineteen million Americans carry the factor V gene that causes blood clots, pulmonary embolism, and heart disease.

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

Did you know?

All adults should have their cholesterol levels checked once every 5 years. During 2009–2010, 69.4% of Americans age 20 and older reported having their cholesterol checked within the last five years.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

For a complete list of videos, visit our video library